These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22964510)

  • 21. Pharmacology aspects during transition and at transfer in patients with epilepsy.
    Chiron C; An I
    Epilepsia; 2014 Aug; 55 Suppl 3():8-11. PubMed ID: 25209078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment resistant epilepsy or convulsive syncope?
    Zaidi A; Clough P; Scheepers B; Fitzpatrick A
    BMJ; 1998 Sep; 317(7162):869-70. PubMed ID: 9748189
    [No Abstract]   [Full Text] [Related]  

  • 23. The course of childhood-onset epilepsy over the first two decades: a prospective, longitudinal study.
    Berg AT; Rychlik K
    Epilepsia; 2015 Jan; 56(1):40-8. PubMed ID: 25431231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Refractory epilepsy: use of the new definition and related risk factors. A study in the Mexican population of a third-level centre].
    Martínez-Juárez IE; López-Zapata R; Gómez-Arias B; Bravo-Armenta E; Romero-Ocampo L; Estévez-Cruz Z; Hernández-De la Cruz G; Morán-Molina S
    Rev Neurol; 2012 Feb; 54(3):159-66. PubMed ID: 22278892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy.
    Pohlmann-Eden B; Crocker CE; Schmidt MH
    Epilepsia; 2013 May; 54 Suppl 2():75-9. PubMed ID: 23646977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
    Summers MA; Moore JL; McAuley JW
    Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy.
    Shneker BF; Fountain NB
    Dis Mon; 2003 Jul; 49(7):426-78. PubMed ID: 12838266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modern management of seizures and epilepsy.
    Gschwind M; Seeck M
    Swiss Med Wkly; 2016; 146():w14310. PubMed ID: 27322347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Update in current care guidelines: epilepsy and febrile seizures (children)].
    Duodecim; 2013; 129(16):1730-1. PubMed ID: 24069643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocardiogenic syncope: frequency and consequences of its misdiagnosis as epilepsy.
    Josephson CB; Rahey S; Sadler RM
    Can J Neurol Sci; 2007 May; 34(2):221-4. PubMed ID: 17598602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.
    Williams S; Hossain M; Ferguson L; Busch RM; Marchi N; Gonzalez-Martinez J; Perucca E; Najm IM; Ghosh C
    Mol Neurobiol; 2019 Dec; 56(12):8392-8407. PubMed ID: 31243719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The methylation hypothesis of pharmacoresistance in epilepsy.
    Kobow K; El-Osta A; Blümcke I
    Epilepsia; 2013 May; 54 Suppl 2():41-7. PubMed ID: 23646970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible interplay between the theories of pharmacoresistant epilepsy.
    Juvale IIA; Che Has AT
    Eur J Neurosci; 2021 Mar; 53(6):1998-2026. PubMed ID: 33306252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of drug-resistant epilepsy].
    Arroyo S
    Neurologia; 1996 Feb; 11(2):56-68. PubMed ID: 8652193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacoresistant epilepsy - epidemiology and current studies].
    Pierzchala K
    Neurol Neurochir Pol; 2010; 44(3):285-90. PubMed ID: 20648993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of drug-resistant epilepsy].
    Arroyo S
    Rev Neurol; 2000 May 1-15; 30(9):881-6. PubMed ID: 10870204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2017 Dec; 18(17):1845-1853. PubMed ID: 29140112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to antiepileptic drug therapy: winners and losers.
    Brodie MJ
    Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance.
    Kim DU; Kim MK; Cho YW; Kim YS; Kim WJ; Lee MG; Kim SE; Nam TS; Cho KH; Kim YO; Lee MC
    J Hum Genet; 2011 Sep; 56(9):640-6. PubMed ID: 21776001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.